ロード中...
The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape
SIMPLE SUMMARY: Interleukin-33 (IL-33) is often released from damaged cells, acting as a danger signal. IL-33 exerts its function by interacting with its receptor suppression of tumorigenicity 2 (ST2) that is constitutively expressed on most immune cells. Therefore, IL-33/ST2 signaling can modulate...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8268428/ https://ncbi.nlm.nih.gov/pubmed/34209038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133281 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|